Image 1
Glyburide Tablet
Product Images NDC 0093-8342
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glyburide (NDC 0093-8342). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
Image 3
This is a description for a medication called Glyburide that's dispensed in the form of 2.5mg tablets. The medication is to be stored at a temperature range of 20°C to 25°C (68°F to 77°F) and comes with complete instructions for use in accompanying literature. The container holding the medication should have a child-resistant closure, and it should be tightly closed at all times. The medication should be kept out of reach of children. It is manufactured in Croatia by PLIVA HRVATSKA and manufactured for TEVA PHARMACEUTICALS USA, INC in North Wales, PA. The NDC code for the medication is 0093-8343-01, and each bottle contains 100 tablets.*
Image 4
This is a description of a medication, Glyburide, available in tablet form with 5mg dose. The recommended dosage for the medication is in the accompanying literature. The medication should be stored at a controlled room temperature of 20° to 25°C (68° to 77°F). The tablets must be kept in a tightly closed, light-resistant container with a child-resistant closure. The medication should be kept out of reach of children. The medication is manufactured by Pliva Hrvatska in Zagreb, Croatia, and is distributed by Teva Pharmaceuticals in North Wales, PA.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
